Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CTAA 28A32, the antigen recognized by MCA 28A32

CTAA 28A32, the antigen recognized by MCA 28A32

US Patent 5521285 · Granted May 28, 1996

Estimated economic value: $816,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Autologous tumor vaccines and methods2022
Botulinum antitoxin compositions and methods2013
Botulinum antitoxin compositions and methods2013
Sterile immunogenic non-tumorigenic tumor cell compositions and methods2009
Sterile immunogenic non-tumorigenic tumor cell compositions and methods2009
In vivo binding pair pretargeting1999
Tumor associated epitope1999
Tumor associated epitope1999
Tumor associated epitope1999
Proteins and novel peptides derived from autoantigen for use in immunotherapy of1998
In vivo binding pair pretargeting1998
High yield preparation of dimeric to decameric chitin oligomers1998